NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,156 | +0.9% | 541 | 0.0% | 0.01% | +7.7% |
| Q2 2023 | $54,642 | +9.7% | 541 | 0.0% | 0.01% | +8.3% |
| Q1 2023 | $49,817 | -19.9% | 541 | -21.1% | 0.01% | -25.0% |
| Q4 2022 | $62,219 | +17.4% | 686 | 0.0% | 0.02% | +14.3% |
| Q3 2022 | $53,000 | -8.6% | 686 | 0.0% | 0.01% | -6.7% |
| Q2 2022 | $58,000 | -3.3% | 686 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $60,000 | 0.0% | 686 | +0.1% | 0.01% | 0.0% |
| Q4 2021 | $60,000 | +7.1% | 685 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $56,000 | -17.6% | 685 | -8.1% | 0.02% | -21.1% |
| Q2 2021 | $68,000 | +17.2% | 745 | +8.9% | 0.02% | +11.8% |
| Q1 2021 | $58,000 | -9.4% | 684 | +0.1% | 0.02% | -19.0% |
| Q4 2020 | $64,000 | +8.5% | 683 | 0.0% | 0.02% | -4.5% |
| Q3 2020 | $59,000 | -1.7% | 683 | 0.0% | 0.02% | -4.3% |
| Q2 2020 | $60,000 | +7.1% | 683 | 0.0% | 0.02% | -8.0% |
| Q1 2020 | $56,000 | -26.3% | 683 | -15.2% | 0.02% | -21.9% |
| Q4 2019 | $76,000 | – | 805 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |